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Abstract 
Objectives: This present study was to evaluate the correlation of Glycated Haemoglobin with diabetic retinopathy in 
various age group of type 2 diabetes mellitus patients. Methods: A detailed assessment like ocular symptoms, duration 
of diabetes, history of use of oral anti hyperglycaemic drugs or insulin and any other history like hypertension or any 
heart disease were performed. Local and systemic examination were done along with ocular examination. Visual 
acuity was done by using Snellen’s chart. Best corrected visual acuity was also recorded. Anterior segment evaluation 
was done with slit lamp. Funduscopy was done and funduscopic photography was taken with the help of Topcon 
Maestro fundus camera. Results: Data was analysed by using simple statistical methods with the help of MS-office 
software. All data was tabulated and percentage was calculated. Conclusions: Retinopathy was commonly seen in 
middle age group diabetic patients. Males were more ponderance than females. Majority of the patients had suffered 
severe non-proliferative diabetic retinopathy from the duration of 20-40 years. And HbA1C level > 14 mmol/L was 
seen in most of the diabetic retinopathy patients. Thus, HbA1C level and diseases duration was significantly associated 
with diabetic retinopathy patients. Hence, now a day, diabetic patients are being referred to ophthalmologists 
according to the type, onset and duration of diabetes. This humane attitude between the family physicians or general 
practitioners and ophthalmologists bears cardinal position in diabetes education programs. 
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Introduction 
Diabetes mellitus (DM) nothing but the disorder of 
glucose homeostasis, has been known to mankind from 
the time immemorial. Worldwide about 415 million 
people are suffering from DM, which is expected to 
increase to 642 million by 2040 [1]. 
HbA1c also called glycated haemoglobin is considered 
as the best available biochemical parameter to assess the 
long-term metabolic control in patients with DM. HbA1c 
levels are closely associated with the response to 
treatment and the risk of developing complications and 
hence it provides the evidence based marker with which 
we can assess the chances of developing 
diabeticcomplications. It provides information about 
overall control of glucose in the previous 6-8 weeks [2]. 
The strong relationship between the reduction of the 
HbA1c level and the beneficial effects on DR has 
obscured the necessity of performing clinical trials 
addressed to investigatethe specific effect of 
hypoglycemic drugs on DR per se, independently of their 
effectiveness in lowering blood glucose levels. The 
reported pleiotropic actions of GLP-1RA in experimental 
models of DR, apart from their capacity in lowering 
blood glucose levels, confer on these drugs a potential 
extra value in preventing the development or arresting 
the progression of DR [3].Objectives of our study was to 
correlate the level of HbA1C with diabetic retinopathy of 
type 2 diabetes mellitus patients. 
Materials & Methods 
This present study was conducted in the Department of 
Ophthalmology, SKMCH, Muzaffarpur, Bihar with 
collaboration of the Department of Ophthalmology, 
PMCH, Patna, Bihar, India during a period from 
February 2019 to December 2019. All the subjects were 
signed an informed consent. Data was collected with 
irrespective of age and sex. 
Patients with type 2 diabetes mellitus with complains of 
visual loss were enrolled in this study. 
Diabetic cataract. gestational diabetes patients, type 1 
diabetes mellitus patient, acute and chronic renal 
failure.congestive heart failure patients and patients with 
hazy media due to dense cataract or anycorneal opacity 
patients were excluded from this study. 
Methods 
A total of 100 patients of type 2 diabetes mellitus with 
age group 20 years to 80 years, who were referredfrom 
endocrinology department for funduscopic examination 
who had complain of vision loss were enrolled in this 
study. 
A detailed medicalhistory like ocular symptoms, 
duration of diabetes, history ofuse oforal anti 
hyperglycaemic drugs or insulin and anyother history 
like hypertension or any heart disease weretaken. Local 
and systemic examination were performed along with 
ocular examination. Visual acuity was done by using 
Snellen’s chart. Best corrected visual acuity was also 
recorded. Anterior segment evaluation was done with slit 
lamp. Funduscopy was done and funduscopic 
photography was taken with the help of Topcon Maestro 
fundus camera. All patients underwent blood test like 
complete blood count, FBS, PPBS, HbA1c test,renal 
function test, lipid profile test was performed. Patients 
were followed up to 3 months. Grading of diabetes was 
done as per Early Treatment Diabetic Retinopathy Study 
(ETDRS). 
Non-Proliferative Diabetic Retinopathy (NPDR)5 
was classified as follows: 
1. No DR
2. Very mild NPDR- Microaneurysms only.
3. Mild NPDR- Any or all of: microaneurysms,
retinalhaemorrhages, exudates, cotton wool spots, up to 
thelevel of moderate NPDR. No intraretinal 
microvascularanomalies (IRMA) or significant beading. 
4. Moderate NPDR:
Severe retinal haemorrhages (more than 
ETDRSstandard photograph 2A: about 20 medium– 
large perquadrant) in 1–3 quadrants or mild IRMA. 
Significant venous beading can be present in no 
morethan 1 quadrant. 
Cotton wool spots commonly present. 
5. Severe NPDR:
The 4–2–1 rule; one or more of: 
Severe haemorrhages in all 4 quadrants. 
Significant venous beading in 2 or more quadrants. 
Moderate IRMA in 1 or more quadrants. 
6. Very Severe NPDR:
Two or more of the criteria for severe NPDR 
Proliferative Diabetic Retinopathy was classified as 
follows: 
1. Mild – Moderate PDR:
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2 
Newvessels on the disc (NVD) or new 
vesselselsewhere (NVE), but extentinsufficient to 
meetthe high-risk. 
2. High Risk PDR:
New vessels on the disc (NVD) greater than ETDRS 
standard photograph 10A (about 1/3 disc area). Any 
NVD with vitreous haemorrhage. 
NVE greater than 1/2 disc area with vitreous 
haemorrhage. 
Statistical Analysis 
Data was analysed by using simple statistical methods 
with the help of MS-office software. All data was 
tabulated and percentage was calculated. 
OBSERVATIONS 
In this present study, we were enrolled a total of 100 
patients of diabetic retinopathy with age ≥ 20 years. Male 
and female ratio was 11:9. Majority of the patients 
41(41%) were in age group of 41-60 years. 
Figure 1: Age wise distribution of patients with diabetic retinopathy 
Table 1:Severity of patients with diabetic retinopathy 
Prevalence No. of patients Percentage 
Mild NPDR 16 16% 
Moderate NPDR 21 21% 
Severe NPDR 44 44% 
Early PDR 15 15% 
High risk PDR 4 4% 
PERCENTAGE OF PATIENTS 
>80 years 0-40 years
12% 18% 
61-80 years 
29% 
41-60 years 
41% 
International Journal of Health and Clinical Research, 2020;3(5):166-171 e-ISSN: 2590-3241, p-ISSN: 2590-325X 
Agarwal et al 
www.ijhcr.com 
International Journal of Health and Clinical Research, 2020; 3(5):166-171 
176 
In this study, most of the cases 44(44%) had severe NPDR. And rest of the cases had moderate 21(21%), mild 
16(16%), early PDR 15(15%)and high risk PDR 4(4%). 
Table 2:Durations of type 2 mellitus with severity of diabetic retinopathy 
Duration Mild NPDR Moderate NPDR Severe 
NPDR 
Early 
PDR 
High risk PDR Total 
<10 years 3(18.75%) 3(18.75%) 7(43.75%) 2(12.5%) 1(6.25%) 16(16%) 
10-20 years 4(16%) 4(16%) 12(48%) 3(12%) 2(8%) 25(25%) 
20-40 years 10(16.95%) 12(20.34%) 25(42.37%) 9(15.25%) 3(5.08%) 59(59%) 
In this present study, most of the patients 59(59%) had 
suffered from diabetic retinopathy from the duration of 
20-40 years. Among them 25(42.37%) severe PDR, 
12(20.34%)  moderate  PDR,  10(16.95%)  mild NPDR, 
9(15.25%) early PDR and 3(5.08%) high risk PDR cases 
were seen. 25(25%) cases had disease duration between  
10-20  years.  Among  them,  12(48%)  severe 
NPDR, 4(16%) moderate and mild NPDR, 3(12%) early 
PDR and 2(8%) high risk PDR were seen. 16(16%) cases 
had suffered with diabetic retinopathy from less than 10 
years. Among them 7(43.75%) severe NPDR, 3(18.75%) 
mild and moderate NPDR, 2(12.5%) early PDR and 
1(6.25%) high risk PDR were seen. 
Table 3: Level of HbA1c in patients with diabetic retinopathy 
HbA1c Mild 
NPDR 
Moderate 
NPDR 
Severe 
NPDR 
Early 
PDR 
High Risk 
PDR 
Total 
7-8.5 1(25%) 1(25%) 1(25%) 1(25%) 0 4(4%) 
8.6-10.5 2(18.18%) 2(18.18%) 4(36.36%) 2(18.18%) 1(9.09%) 11(11%) 
10.6-12.5 4(22.22%) 2(11.11%) 7(38.89%) 4(22.22%) 1(5.56%) 18(18%) 
12.6-14.5 4(16.67%) 6(25%) 10(41.67%) 3(12.5%) 1(4.17%) 24(24%) 
>14.5 4(9.30%) 7(16.28%) 25(58.13%) 5(11.63%) 2(4.65%) 43(43%) 
Total 15(15%) 18(18%) 47(47%) 15(15%) 5(5%) 100(100%) 
In this present study, majority of cases 43(43%) had 
HbA1c levels >14.5 mmol/L. Among them, 25(58.13%) 
severe NPDR, 7(16.28%) moderate NPDR, 5(11.63%) 
early PDR, 4(9.30%) mild NPDR and 2(4.65%) high risk 
PDR. 24(24%) cases had HbA1C level between 12.6-
14.5 mmol/L HbA1c level. Among them 10(41.67%) 
severe PDR, 6(25%) moderate NPDR, 
4(16.67%) mild NPDR, 3(12.5%) early PDR and 
1(4.17%) high risk PDR.18(18%) diabetic retinopathy 
cases had HbA1C level between 10.6-12.5.Among them 
7(38.89%) severe NPDR, 4(22.22%) mild NPDR and 
early PDR, 2(11.11%) moderate NPDR and 1(5.56%) 
high risk PDR. 11(11%) diabetic retinopathy patients had 
HbA1C level between 8.6-10.5 mmol/L. Among 
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them 4(36.36%) severe NPDR, 2(18.18%) mild NPDR, 
moderate NPDR, early PDR and 1(9.09%) high risk 
PDR. 4(4%) patients had HbA1C level between 7-8.5 
mmol/L. Among them1(25%) cases had mild NPDR, 
moderate NPDR, severe NPDR and early PDR. 
Discussion 
Type 2 diabetes is now a common and serious global 
health problem, which, for most countries, has evolved 
in association with rapid cultural and social changes, 
ageing populations, increasing urbanisation, dietary 
changes, reduced physical activity and other unhealthy 
lifestyle and behavioural patterns. The risk of developing 
diabetic retinopathy or other microvascular 
complications of diabetes depends on both the duration 
and severity of hyperglycemia [4]. 
In this present study, most of the diabetic retinopathy 
patients were belonged in age group of 41-60 years. 
Males were more ponderance than females. 
A study done by Leske et al, [4] in Barbodose eye study, 
they found that every 1% increase in HbA1C from 
baseline was associated with a >2-fold risk of DR, upto 
4 years of follow up which was correlating with the 
present study in telling the linear relationship of HbA1c 
levels with the development of DR [4]. Many other 
epidemiological studies also confirm that uncontrolled 
sugars which is assessed by HbA1c is important risk 
factor for DR [5,6]. 
In this study, most of the cases 44(44%) had severe 
NPDR. And rest of the cases had moderate 21(21%) 
cases had moderate NPDR. 59(59%) patients had 
suffered from diabetic retinopathy from the duration of 
20-40 years. Among them 25(42.37%) had severe PDR, 
12(20.34%) moderate PDR, 10(16.95%) mild NPDR, 
9(15.25%) early PDR and 3(5.08%) high risk PDR cases 
were seen. 25(25%) cases had suffered from10-20 years. 
A study was done by Yun [7] in 2010 on the association 
between DR and HbA1c concluded that DR was 
significantly more in patients having higher levels of 
HbA1c (odds ratio=3.46). Elevated HbA1c have been 
seento be associated with increased severity of DR, i.e., 
from Non-Proliferative Diabetic Retinopathy (NPDR) to 
PDR [8]. Complication of diabetes such as DR can be 
detectedat the time of the first diagnosis of diabetes [9]. 
Therelationship between DR and HbA1c values have 
beenstudied by many authors, and almost all the studies 
werein accord and pointed out that elevated HbA1c 
level issignificantly associated with the development of 
DR [10,11]. 
In our study, majority of cases 43(43%) had HbA1c 
levels >14.5 mmol/L. Among them, 25(58.13%) severe 
NPDR, 7(16.28%) moderate NPDR, 5(11.63%) early 
PDR, 4(9.30%) mild NPDR and 2(4.65%) high risk PDR. 
24(24%) cases had HbA1C level between 12.6- 
14.5 mmol/L HbA1c level. Among them 10(41.67%) 
severe PDR, 6(25%) moderate NPDR, 4(16.67%) mild 
NPDR, 3(12.5%) early PDR and 1(4.17%) high risk 
PDR. 18(18%) diabetic retinopathy cases had HbA1C 
level between 10.6-12.5. Among them 7(38.89%) severe 
NPDR, 4(22.22%) mild NPDR and early PDR, 
2(11.11%) moderate NPDR and 1(5.56%) high risk PDR. 
11(11%) diabetic retinopathy patients had HbA1C level 
between 8.6-10.5 mmol/L. Among them 4(36.36%) 
severe NPDR, 2(18.18%) mild NPDR, moderate NPDR, 
early PDR and 1(9.09%) high risk PDR. 4(4%) patients 
had HbA1C level between 7-8.5 mmol/L. Among 
them1(25%) cases had mild NPDR, moderate NPDR, 
severe NPDR and early PDR. 
Lokesh S et al. [12] were studied on severity of diabetic 
retinopathy in relation to value of HbA1. In their study, 
data shows that severe form of DR (including severe 
NPDR, PDR and CME) are more commonly distributed 
among the patients with higher HbA1c as compared to 
lower HbA1c group. However milder form of DR 
(including mild and moderate NPDR) are more in 
patients with HbA1c <10.0 compared to the patients with 
HbA1c >10.0 32% of patient had fasting blood sugars 
more than 200, 48% of patients had fasting blood sugars 
in the range of 126-199 and 20% had Fasting blood 
sugars less than 126. 80% of patients had PPBS more 
than 200 [12]. 
Conclusion 
This present study concluded that retinopathy 
complication was commonly seen in middle age group 
diabetic patients. Males were more ponderance than 
females. Majority of the patients had suffered severe 
non-proliferative diabetic retinopathy from the duration 
of 20-40 years and HbA1C level > 14 mmol/L was seen 
in most of the diabetic retinopathy patients.Thus, HbA1C 
level and diseases duration was significantly associated 
with diabetic retinopathy. Hence, now a day, diabetic 
patients are being referred to ophthalmologists according 
to the type, onset and duration of diabetes. As evidence 
of strong link between DR and HbA1c is rising, it is time 
to consider HbA1c level as one of the proposed factors 
that may influence the referral. The 
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treating doctor should persuade the patientsto undergo 
screening for retinopathy whether needed or not. This 
humane attitude between the family physiciansor general 
practitioners and ophthalmologists bears cardinal 
position in diabetes education programs. 
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